Intrinsic Value

Is KAPA undervalued or overvalued?

See the intrinsic value estimate for Kairos Pharma Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

KAPA Intrinsic Value
LOCKED
Unlock
Today vs. history

KAPA looks undervalued.
But is it cheap by its own standards?

See how today’s valuation compares with KAPA’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor KAPA
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Intrinsic Value Locked
Margin of Safety 20% Locked
Current Price $0.83
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to KAPA

Fundamental Analysis

What Kairos Pharma Does

Kairos Pharma Ltd is a clinical-stage drug developer focused on cancer. It does not sell a broad line of products; instead, it builds and tests experimental therapies designed to help doctors treat tumors that resist standard treatment. Its work centers on oncology programs that aim to change how cancer cells interact with the immune system and surrounding tissue.

Headquarters
United States of America US
IPO date
Sep 16, 2024
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Kairos Pharma Ltd

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Ownership

KAPA Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one KAPA stock?

The intrinsic value for Kairos Pharma Ltd (KAPA) under the Base Case is hidden USD.

Is KAPA stock undervalued or overvalued?

Compared with the current market price of 0.8287 USD, the stock appears hidden.

Back to Top